Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions
Status:
RECRUITING
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This is an open-labeled, randomized, two period, single-center, crossover, comparative study, where each participant will be randomly assigned to the reference (Prestarium ® A 10 mg tablets) or the test (Perindopril 8 mg tablets) formulation in each period of study (sequences Test-Reference (TR) or Reference-Test (RT)), in order to evaluate if both formulations are bioequivalent.